A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
Public ClinicalTrials.gov record NCT00817635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Multi-center, Dose Ranging Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Resistant Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the blood pressure effect, safety and tolerability of LCI699 compared to placebo and eplerenone in participants with resistant hypertension.
Study identification
- NCT ID
- NCT00817635
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Interventions
- LCI699 Drug
- Eplerenone Drug
- LCI699-matching Placebo Drug
- Eplerenone-matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 22, 2008 (Actual)
- Primary completion
- Oct 13, 2009 (Actual)
- Completion
- Oct 13, 2009 (Actual)
- Last update posted
- Jun 2, 2021
2008 – 2009
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Horizon Research Group, Inc | Mobile | Alabama | 36608 | — |
| Cochise Clinical Research | Sierra Vista | Arizona | 85635 | — |
| Clinical Solutions Advantage | Buena Park | California | 90620 | — |
| Michael Waldman, MD | Irvine | California | 92618 | — |
| Long Beach Center for Clinical Research | Long Beach | California | 90806 | — |
| Clinical Trials Research | Roseville | California | 95661 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Metro Clinical Research | Littleton | Colorado | 80120 | — |
| Meridien Research | Bradenton | Florida | 34203 | — |
| Clinical Research of So. Florida | Coral Gables | Florida | 33134 | — |
| Jacksonville Heart Center | Jacksonville Beach | Florida | 32250 | — |
| FPA Clinical Research | Kissimmee | Florida | 34741 | — |
| Accelovance | Melbourne | Florida | 32935 | — |
| Cardio-Pulminary Associates | Plantation | Florida | 33317 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| Northwest Clinical Trials | Boise | Idaho | 83704 | — |
| Provident Clinical Research | Addison | Illinois | 60101 | — |
| Cedar-Crosse Research Centereet | Chicago | Illinois | 60607 | — |
| Provident Clinical Research | Bloomington | Indiana | 47403 | — |
| Accelovance | South Bend | Indiana | 46601 | — |
| Peter A. Holt | Baltimore | Maryland | 21239 | — |
| MD Medical Research | Oxon Hill | Maryland | 20745 | — |
| Chelsea Internal Medicine | Chelsea | Michigan | 48118 | — |
| New York Cardiovascular Associates | New York | New York | 10001 | — |
| Charlotte Clinical Research | Charlotte | North Carolina | 28211 | — |
| Northstate Clinical Research | Lenoir | North Carolina | 28645 | — |
| Community Research | Cincinnati | Ohio | 45245 | — |
| Tipton Medical & Diagnostic Center | Tipton | Pennsylvania | 16684 | — |
| Medical Research South | Charleston | South Carolina | 29407 | — |
| Mountain View Clinical Research Associates | Greer | South Carolina | 29651 | — |
| Clinical Research Associates, Inc | Nashville | Tennessee | 37203 | — |
| Punzi Medical Center | Carrollton | Texas | 75006 | — |
| KRK Medical Research | Dallas | Texas | 75230 | — |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | — |
| Daniel Gottlieb, MD | Burien | Washington | 98166 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
| Gemini Scientific | Madison | Wisconsin | 83719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00817635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00817635 live on ClinicalTrials.gov.